Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NOD-like receptor signaling pathway comprises intracellular proteins known as NOD-like receptors (NLRs), which act as sensors for pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) within the cytosol. These receptors are structurally defined by a central nucleotide-binding domain, leucine-rich repeats for ligand recognition, and variable N-terminal effector domains. Upon activation by microbial or stress signals, NLRs oligomerize and recruit various adaptor proteins, forming complexes such as inflammasomes (notably NLRP3), and activate downstream immune signaling cascades (NF-κB, MAPKs, IRFs). This leads to the production of pro-inflammatory cytokines, regulation of autophagy, and orchestration of innate and, indirectly, adaptive immune responses. NLR pathway dysregulation is implicated in numerous human diseases including chronic inflammation, autoimmunity, cancer, and infection susceptibility. Therapeutic investigation is ongoing, focusing on selective modulation of specific NLRs in disease contexts (with NLRP3 as a particularly prominent target).
Inhibition or activation of NLRs to modulate inflammasome assembly; Blockade of cytokine release (e.g., IL-1β, IL-18); Modulation of downstream signaling (NF-κB, MAPK); Targeting upstream PAMP/DAMP recognition
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOD-like receptor signaling pathway (NLR signaling pathway).